No matter where you go, there will always be loans and dilution in the public markets. If a company operates genuinely in my view, I'm fine with it. I may not commit to holding the stock indefinitely, but I won't criticize people or be irrationally stupid to blame others for my actions. Everyone has their history and, their behavior and I respect that.
Regarding BDPT, I perceive it as a genuine company with marketable products, lacking only the right marketing strategy to boost sales. BDPT's market cap of 543k with an extremely low outstanding share count is laughable to me. It's rare to find a sub-penny stock with only 776M outstanding shares that hasn't diluted since July.
Looking at the next trench with the lowest offer at .001, even if the outstanding shares remain at one billion, the market value would be just 1 million at .001. Compare this to other stocks like AAGH with a .011 price and 21 billion outstanding shares, ASTA at .0029 with 6 billion shares, or SPZI at .0009 with 5.4 billion outstanding shares, which I saw a stock run of +375% today. There are numerous examples. Considering this, BDPT appears undervalued to me. I won't hesitate to purchase at this attractive price. No pumping is needed, it's as straightforward as that; simple buy/sell make what you want out of it.
Examine the stock price movement. Analyze the market activity, and you'll notice a significant disparity between the number of buyers and the minimal selling reflected on the tape. Despite dilution and the influence of short sellers, a substantial rebound seems inevitable. The timing of this rebound is uncertain—it could happen within a day or stretch over a week. Imho.
Yesterday, I confirmed that the TA share structure remains unchanged. Currently, I'm occupied with developing an RV park on my property with 42 units, which means I have limited time to focus on the market. However, this doesn't imply that I've completely withdrawn from the market or lost interest in BioAdaptives Inc.
Selling at this price level would be an action taken by someone desperate for money, and it's not a rational move for those in their right mind. I've consistently mentioned my exclusive interest in the spin-off, and if the company fails to execute its business plan effectively, life moves on. Despite this, I still hold a significant number of shares. I've been supporting this stock since it was at .0004, repeatedly advising people to take profits on the way up. Trading should be about making money; if people aren't making money, perhaps trading isn't suitable for them.
Make no mistake this stock isn't dead; it has an exceptionally low outstanding share count for a triple 0 stock. There will be moments when it will shine again.
As I've emphasized from the start, the success of DD notwithstanding, effective management execution is paramount. Finalizing the spin-off is a critical step. They are dedicating excessive time to new product development without addressing long-term financial working capital issues is concerning. The spin-off presents a solution, but it appears that there is a lack of urgency in addressing this crucial matter.
AAPJ SECURITY DETAILS: SS UPDATE UNCHANGED. NO DILUTION.
Market Cap Market Cap
Held at DTC
I've discussed this matter with you extensively. If you're still uncertain, please refer to the link below where I've provided my previous explanation.
As of the present date, LiveStock is still on the books of BioAdaptives, Inc. because the Livestock Impact Division was initially a wholly-owned subsidiary. Don't distort information to mislead readers when you can't fully grasp the financial details in the filings.
Let's clarify something upfront: The BDPT spin-off has not yet taken place. The false information being circulated here claims the spin-off has already occurred, which is both inaccurate and misleading. It appears that some individuals are still unaware of the spin-off process, and I've provided a comprehensive explanation in the link below.
Let's put an end to spreading false information and baseless rumors. When I endorse someone's statement, those are their words, not mine.
DSS operates nine business divisions they spun off two divisions.
I want to see them finalize and announce the details of the spin-off news. This announcement can provide clarity and information for investors and stakeholders.
How is it possible for a company that didn't generate ANY REVENUE in 2022 and recorded a loss of $7.26 million to proceed with a spin-off and plan to sell 2 million shares for $3 to $5 in its initial public offering? How is it possible for a company trading at just 14 cents to spin off a subsidiary and sell 2 million shares for $3 to $5 each? Surprisingly, this scenario is happening right now, and it's not uncommon in the stock market.
Does this scenario apply similarly to the $BDPT case? Let's consider all the facts; please take a closer look at the link below:
Published: Nov. 1, 2023.
I'm retaining my share since selling it at this moment doesn't make sense. Besides, there's no benefit in engaging in arguments with these nonstop stupid nonsense, and irrational individuals.
In my previous post, I provided a clear explanation of the spin-off. That will be my final due diligence (DD) post for you. I won't be answering any more questions posted here or providing guidance here from this point on.
In my last post, I explained clearly the spin-off. That is my final DD post for you. No more questions and guidance answers on my end. If you have any questions, please send me a private message, and I'll address them through PM.